The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Worldquant Millennium Advisors LLC

Worldquant Millennium Advisors LLC raised its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 1,701.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 76,854 shares of the medical device company's stock after purchasing an additional 72,587 shares during the period. Worldquant Millennium Advisors LLC's holdings in Cooper Companies were worth $8,480,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Innealta Capital LLC acquired a new position in Cooper Companies in the second quarter valued at approximately $25,000. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies in the 3rd quarter valued at $25,000. Crewe Advisors LLC grew its position in shares of Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock valued at $30,000 after buying an additional 252 shares during the last quarter. Tortoise Investment Management LLC raised its stake in Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock worth $34,000 after acquiring an additional 169 shares in the last quarter. Finally, Covestor Ltd lifted its position in Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded down $4.53 on Friday, reaching $98.70. 3,694,024 shares of the stock were exchanged, compared to its average volume of 1,287,907. The firm has a market capitalization of $19.66 billion, a PE ratio of 50.62, a PEG ratio of 2.28 and a beta of 0.97. The Cooper Companies, Inc. has a 1-year low of $82.69 and a 1-year high of $112.38. The business has a fifty day moving average price of $104.49 and a two-hundred day moving average price of $98.80. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.03 billion. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 EPS. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 4.03 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares of the company's stock, valued at approximately $520,488.54. This represents a 24.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares of the company's stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on COO. Wells Fargo & Company lifted their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday. Morgan Stanley cut their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Friday. StockNews.com raised Cooper Companies from a "hold" rating to a "buy" rating in a report on Tuesday, December 3rd. Citigroup reduced their price target on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research report on Friday. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.